Association of Elevated Lipoprotein(a) and Diabetes Mellitus With Survival Outcomes in Patients With Coronary Artery Disease: Findings From the CIN-II and RED-CARPET Cohorts.
Key Points
This research investigates how elevated lipoprotein(a) and diabetes mellitus affect survival outcomes in patients with coronary artery disease.
Analyze data from the CIN-II and RED-CARPET cohorts
Assess levels of lipoprotein(a) and diabetes status
Evaluate survival outcomes and mortality rates
Elevated lipoprotein(a) significantly increases mortality risk in CAD patients
Diabetes mellitus also contributes to higher mortality
Both conditions together lead to a synergistic effect on survival outcomes
Abstract
In patients with CAD, elevated Lp(a) and DM act synergistically to increase the risk of cardiovascular and all-cause mortality, suggesting that both risks should be considered to integrate management.
Like
Bookmark
Share
Like
Bookmark
Share
Association of Elevated Lipoprotein(a) and Diabetes Mellitus With Survival Outcomes in Patients With Coronary Artery Disease: Findings From the CIN-II and RED-CARPET Cohorts. | Synapse